Gif-sur-Yvette, France

Poon Beng Teng

This inventor holds 2 USPTO granted patents. Top assignee: Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.). Active years: 2004-2006.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Poon Beng Teng: Innovator in DNA Polymerase Inhibitors

Introduction

Poon Beng Teng is a notable inventor based in Gif-sur-Yvette, France. He has made significant contributions to the field of medicine, particularly in the development of DNA polymerase inhibitors. With a total of 2 patents, his work focuses on innovative methods for treating proliferative diseases in warm-blooded animals.

Latest Patents

Poon Beng Teng's latest patents include groundbreaking inventions related to DNA polymerase inhibitors, specifically mikanolide and dihydromikanolide. One of his patents describes a method of treating proliferative diseases in warm-blooded animals by administering compounds from the group consisting of mikanolide and dihydromikanolide. This method aims to provide effective treatment for various diseases. Another patent focuses on the use of these compounds or their enriched extracts for preparing medicines designed to combat proliferative diseases, including cancer, viral diseases, and parasitic diseases such as malaria.

Career Highlights

Poon Beng Teng is associated with the Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS), where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

Throughout his career, Poon Beng Teng has collaborated with esteemed colleagues, including Marie-Christine Brezak Pannetier and Mohamed Moumen. These collaborations have contributed to the development and refinement of his innovative ideas.

Conclusion

Poon Beng Teng stands out as a significant figure in the field of medical innovation, particularly with his work on DNA polymerase inhibitors. His contributions have the potential to change the landscape of treatment for proliferative diseases, showcasing the importance of research and development in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…